© 2 0 1 9 I n d I a n J o u r n a l o f P a t h o l o g y a This year, we intend to publish a special issue on "Genito-Urinary-Gynecologic pathology including breast." This issue will feature interesting articles on the topics including renal system with urinary bladder, male genital system, female genital system, and breast.
Molecular cloning nowadays forms an integral part of diagnosing cancer. The genomic DNA for ERCC1 was the first human DNA repair gene to be isolated by molecular cloning. During cell replication, the damage caused to the DNA is repaired by several pathways, thus finally protecting the material. During chemotherapy, if a particular pathway is deficient, it leads to nonrepair of the damaged tumor cell DNA, thus improving the therapeutic response of the drug in use. The article by Foda et al. has meticulously expressed the role of ERCC1 in colorectal adenoma-carcinoma sequence, giving an insight into its use in cancer. [1] The guest editorial by Bansal has further narrated the role of ERCC1 as a biomarker in good detail. [2] The article by Gupta et al. has tried to evaluate metastatic brain tumors with unknown primary using a panel of immunohistochemical markers along with a clinicoradiological correlation. [3] I am sure that the readers would gain a lot from this article. Carcinoma of the gall bladder is one of the notorious malignancies with a high rate of invasion and poor outcome. Increased levels of Oct-4 cancer stem cell marker are now considered to be an indicator of malignant gall bladder lesions, thus affecting the stage and grade of tumor. Analysis of Oct-4 thus ultimately affects patient survival. The research publication by Fatima et al. illustrates these details. [4] Gahlot et al. via their research publication generated an interest wherein it needs to be proved that the assessment of the functionality of the intestinal mucosal immune system may yield significant information regarding the pathogenesis of celiac disease.
